INC Research, Inc. Expands Therapeutic Focus with Infectious Disease Capabilities; Acquisition of Advanced Biologics Gives INC Research, Inc. Full-service Facility with Renowned Expertise

RALEIGH, N.C.--(BUSINESS WIRE)--INC Research®, a therapeutically focused contract research organization with a trusted process for delivering reliable results, today announced the strategic acquisition of Advanced Biologics to strengthen its Infectious Disease practice. Advanced Biologics is a full-service contract research organization (CRO) specializing in full-service clinical development to the pharmaceutical and biotechnology industries worldwide.